Why the study?
Peripartum cardiomyopathy causes significant maternal and fetal disability and mortality, but nonspecific complaints and sparse early clinical symptoms lead to delayed diagnosis and unfavorable outcomes.
Highlights the severe complications of peripartum cardiomyopathy, including cardiogenic shock and fetal death, emphasizing the need for early diagnosis.
Emphasizes vigilance for peripartum cardiomyopathy amid pregnancy hemodynamic shifts; leaves open standardized early-detection protocols.
The cardiovascular system during pregnancy undergoes a number of compensatory and adaptive changes, such as an increase in heart rate, cardiac output and total peripheral resistance, which causes an increase in the load on the myocardium. Peripartum cardiomyopathy is a serious polyetiological complication of pregnancy and the postpartum period, as well as an important cause of disability and mortality for both mother and fetus. The non-specificity of complaints and the paucity of clinical symptoms in the early stages of the disease lead to delayed diagnosis and significantly increase the frequency of unfavorable outcomes. In the article we present our own clinical observation of the acute development of severe peripartum cardiomyopathy in a multipregnant woman at 36 weeks of gestation, complicated by cardiogenic shock and antenatal fetal death.
No takes yet. Share an insight, caveat, or question.
Panchuk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: